Centene Corporation Reaffirms 2023 Adjusted Earnings Guidance

Strategic Insights -

Centene Corporation has filed a Form 8-K with the U.S. Securities and Exchange Commission, reaffirming its 2023 Adjusted Diluted Earnings Per Share (EPS) annual guidance of at least $6.45. This announcement comes ahead of the company's presentation at the Wells Fargo 2023 Healthcare Conference on September 6, 2023. The company also reaffirms its previously issued 2024 Adjusted EPS floor of greater than $6.60. Centene's executives will be presenting at the conference and a live audio webcast will be available for those unable to attend in person.

Key Takeaways:

  • Centene Corporation has reaffirmed its 2023 Adjusted Earnings Per Share (EPS) annual guidance of at least $6.45, inclusive of July results.
  • The company has also reaffirmed its 2024 Adjusted Earnings Per Share (EPS) floor of greater than $6.60.
  • Centene will be presenting at the Wells Fargo 2023 Healthcare Conference on September 6, 2023, at 8:45 a.m. Eastern Daylight Time (EDT).
  • A simultaneous live audio webcast and replay of the presentation will be available on the company's website at www.centene.com.
  • Centene's forward-looking statements are subject to a variety of risks and uncertainties, including but not limited to changes in healthcare practices, new technologies, and advances in medicine.

Statistics:

  • 2023 Adjusted Earnings Per Share (EPS) annual guidance: at least $6.45.
  • 2024 Adjusted Earnings Per Share (EPS) floor: greater than $6.60.
  • Date of presentation at Wells Fargo 2023 Healthcare Conference: September 6, 2023.
  • Time of presentation at Wells Fargo 2023 Healthcare Conference: 8:45 a.m. Eastern Daylight Time (EDT).

Sources:

  • United States Securities and Exchange Commission (SEC) filing, Form 8-K, dated September 6, 2023.
  • Wells Fargo 2023 Healthcare Conference presentation by Centene Corporation, scheduled for September 6, 2023.